Concepedia

Paul Berger

PB

23

Publications

1.4K

Citations

21

H-Index

1975

Active since

Affiliations

Yale University(Current)

National Institutes of Health

University of California, San Francisco

National Institute of Diabetes and Digestive and Kidney Diseases

Stanford University

Paul Berger is an author at Yale University specializing in medicine, neuroscience, and neuropharmacology.

Top concepts

Publications per year

1975–2024

23

Publications

23

Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential.

Wolfgang-M. Franz, Paul Berger, Jiu‐Yao Wang · The EMBO Journal · 1989 · 207 citations · Full text

, , +10

Characterization of Sodium‐Dependent [<sup>3</sup>H]GBR‐12935 Binding in Brain: A Radioligand for Selective Labelling of the Dopamine Transport Complex

Aaron Janowsky, Paul Berger, Frank J. Vocci et al. · Journal of Neurochemistry · 1986 · 173 citations

, , +22

Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine

Frank R. Sharp, M. Butman, S. Wang et al. · Journal of Neuroscience Research · 1992 · 107 citations

, , +12

Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis.

Keith L. Davis, Paul Berger · PubMed · 1978 · 102 citations

[3H]GBR-12935: A specific high affinity ligand for labeling the dopamine transport complex

Paul Berger, Aaron Janowsky, Frank J. Vocci et al. · European Journal of Pharmacology · 1985 · 99 citations

, , +12

Rows per page

1–5 of 23